Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

Background Olfactory dysfunction (OD) is common and has been reported as an early
indicator of COVID-19. However, the reported prevalence of OD in the general population …

Background Chronic rhinosinusitis with nasal polyps affects approximately 2–4% of the
general population, and long-term use of systemic corticosteroids is associated with adverse …

Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have
a high symptom burden and poor health-related quality of life, often requiring recurring …

ABSTRACT BACKGROUND Loss of smell is one of the most troublesome and difficult-to-
treat symptoms of severe chronic rhinosinusitis with nasal polyps (CRSwNP). OBJECTIVE …

Disorders causing a loss of the sense of smell remain a therapeutic challenge. Basic
research has, however, greatly expanded our knowledge of the organization and function of …

Background Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with
a substantial personal and socioeconomic burden. Monitoring of patient‐reported outcomes …

Anosmia, the loss of sense of smell, is a common nonmotor feature of Parkinson's disease
(PD). Ageusia, the loss of sense of taste, is additionally an underappreciated nonmotor …

Background Olfactory dysfunction is highly associated with chronic rhinosinusitis with nasal
polyps (CRSwNP), and the severity of loss has been linked with biomarkers of type 2 …

Background Patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) often
require repeat sinus surgery. Mepolizumab reduced the need for sinus surgery in the …